iSpecimen Inc ISPC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $2.32
- Day Range
- $2.22–2.37
- 52-Week Range
- $2.06–127.20
- Bid/Ask
- $2.30 / $2.35
- Shares Outstanding
- 1.52M
- Market Cap
- $3.31M
- Volume/Avg
- 18,488 / 403,068
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.23
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 7
- Website
- https://www.ispecimen.com
Valuation
|
Metric
|
ISPC
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.11 |
Price/Sales | 0.23 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ISPC
|
|---|---|
Quick Ratio | 0.53 |
Current Ratio | 0.62 |
Interest Coverage | −4,681.94 |
Quick Ratio
ISPC
Profitability
|
Metric
|
ISPC
|
|---|---|
Return on Assets (Normalized) | −146.63% |
Return on Equity (Normalized) | −601.63% |
Return on Invested Capital (Normalized) | −523.48% |
Return on Assets
ISPC
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|<TsfKnvB | LOCK|L#x | $198B | |||
| Danaher Corp
DHR
| LOCK|^#bV^Yc^ | LOCK|Ph$ | $144B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|<#@Rx%>L | LOCK|cL< | $45B | |||
| Agilent Technologies Inc
A
| LOCK|LDpPw<& | LOCK|w$ | $37B | |||
| Waters Corp
WAT
| LOCK|#vzqs&> | LOCK|DNb | $36B | |||
| IQVIA Holdings Inc
IQV
| LOCK|Z^^hZQ^ | LOCK|#k!Fb | $34B | |||
| Illumina Inc
ILMN
| LOCK|d!^s@? | LOCK|#Bh%L | $28B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|j#w@&>#& | LOCK|bGwr | $26B | |||
| Quest Diagnostics Inc
DGX
| LOCK|xyl!b? | LOCK|WlGD | $23B | |||
| Labcorp Holdings Inc
LH
| LOCK|?<R&kF?% | LOCK|vY!P^ | $23B |
United States